By Claire Jeong, Vice President of Investor Research, Asia BD, LSN
With one month left until the next Digital Redefining Early Stage Investments (RESI) September Conference (September 14-16), we are very excited to highlight some of the key speakers who will be contributing to our virtual panels.
These speakers are all investors and strategic partners who actively invest in and work with early-stage life science and healthcare companies, with diverse interests within therapeutics, medical devices, diagnostics, and digital health.
Digital RESI September registrants get to hear from the leading industry experts about their investment strategies and differentiated approaches, recent investments and areas of interest, and more.
Here are some of the panelists joining us:
 Jun Deng Investment Partner Joyance Partners |
 Prathna Ramesh Executive Director Maple Leaf Angels (MLA) |
 Nancy Torres Kaufman CEO Beacon Capital |
 Steve Yoder Vice President, Business Development Taiho Oncology Inc |
 Duncan Young Director, Search and Evaluation Oncology, BD&L AstraZeneca |
 Barbara Lavery Chief Program Officer Alliance for Cancer Gene Therapy |
 Mark Krul Partner Aglaia Oncology Funds |
 Weiyong Sun Senior Director, Specialty Medicine Search & Evaluation Daiichi Sankyo |
 Fiona Mack Head of JLABS TMCx Johnson & Johnson Innovation |
 Chris Haskell VP, Head of West Coast Innovation Center Bayer |
 Yao Li Ho Senior Director of Business Development LYFE Capital |
 Haolin Sung Managing Partner Chaperone Investment |
 Christina Salys Sr. Mgr. New Business Development Intuitive Surgical |
 Rupert Winckler Head of EMEA New Business Development Olympus Corporation |
 William Dai Founding Partner ShangBay Capital |
 Benedikt Luhmann Principal – Healthcare VI Partners |
 Norm Gitis Founder, Managing Partner Lymo Ventures |
 Paul Larkin Manager, Research Innovation Crohn’s and Colitis Foundation |
 Michael Cole Founder and General Partner Global Neurohealth Ventures |
 Lore Gruenbaum Vice President, Therapy Acceleration Program Leukemia & Lymphoma Society (LLS) |
 Kuldip Dave Vice President of Research ALS Association |
 Chris Penland VP BioPharma Programs Cystic Fibrosis Foundation |
 Mayank Taneja Director of Venture Investments OSF Healthcare Ventures |
 Cyril Philip Principal Providence Ventures |
 Rajesh Aggarwal Executive Vice President Jefferson Strategic Ventures |
 Linda Maxwell Director Biomedical Zone |
 Ron Paliwoda Founder and President Paliwoda Group |
 Marcia Dawood Managing Partner Individual Angel |
 Merom Klein Entrepreneur Mentor Keiretsu Forum |
 Laura Davis Managing Director Golden Seeds |
 Rob Manning Chairman Cherrystone Angel Group |
 Sascha Berger Partner TVM Capital Life Science |
 Haruhiko Sugino Director, Global Business Development Otsuka Pharmaceuticals |
 Bibhash Mukhopadhyay Principal New Enterprise Associates |
 Jayson Punwani Senior Partner Takeda Ventures |
 Scott Weiner Partner Amzak Health |
 Roy Wiesner Managing Director aMoon Fund |
 Robert Garber Partner 7wire Ventures |
 Evan Cohen Associate Principal, Strategic Investing Healthbox |
 Ben Evans Investment Director InHealth Ventures |
 Netalie Nadivi Partner TriVentures |
 Rick Jones Partner BioAdvance |
 Katherine Hill Ritchie Director Nottingham Spirk Family Office |
 Mark Ralph Executive Director Boehringer Ingelheim Venture Fund |
Please contact RESI@lifesciencenation.com if you are interested in any speaking opportunities!
Next Phase Newsletter 
Leave a Reply